Kabra Drugs informs about standalone financial results

15 Nov 2016

Kabra Drugs has informed about Standalone Financial Results for the period ended September 30, 2016 and Standalone Limited Review for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

4.51 0.00 (0.00%) Feb 22, 18:47
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 627.40
Dr. Reddys Lab 4780.60
Lupin 1037.15
Piramal Enterprises 1715.00
Cadila Healthcare 488.55
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback